Neutrophil dysfunction after biomaterial contact in an in vitro model of cardiopulmonary bypass

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 5, 2006, Pages 744-748

  Åsberg, Ann E ^a,b   Videm, Vibeke ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adhesion; Endothelial cells; Inflammation; Neutrophil; Polyvinylchloride

Indexed keywords

BIOMATERIAL; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GELATIN; PHORBOL 13 ACETATE 12 MYRISTATE; POLYVINYLCHLORIDE;

ARTICLE; CARDIOPULMONARY BYPASS; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; EXHAUSTION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LEUKOCYTE DISORDER; NEUTROPHIL; PRIORITY JOURNAL; PUMP; TISSUE INJURY; VASCULAR ENDOTHELIUM;

BIOCOMPATIBLE MATERIALS; CARDIOPULMONARY BYPASS; CELL ADHESION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GELATIN; HUMANS; MODELS, CARDIOVASCULAR; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; NEUTROPHILS; POLYVINYL CHLORIDE; SURFACE PROPERTIES; TETRADECANOYLPHORBOL ACETATE;

EID: 33750006267     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.08.019     Document Type: Article

References (22)

1. Paparella D., Yau T.M., and Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 2 (2002) 232-244
2. Levy J.H., and Tanaka K.A. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75 2 (2003) S715-S720
3. Hattori T., Khan M.M., Colman R.W., and Edmunds Jr. L.H. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds. J Am Coll Cardiol 46 4 (2005) 707-713
4. Gorbet M.B., and Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25 26 (2004) 5681-5703
5. Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97 1 (2002) 215-252
6. Grover F.L. The Society of Thoracic Surgeons National Database: current status and future directions. Ann Thorac Surg 68 2 (1999) 367-373 discussion 374-6
7. Murphy G.J., and Angelini G.D. Side effects of cardiopulmonary bypass: what is the reality?. J Card Surg 19 6 (2004) 481-488
8. Partrick D.A., Moore E.E., Fullerton D.A., Barnett J.C.C., Meldrum D.R., and Silliman C.C. Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. J Surg Res 86 1 (1999) 42
9. Biffl W.L., Moore E.E., Zallen G., Johnson J.L., Gabriel J., Offner P.J., and Silliman C.C. Neutrophils are primed for cytotoxicity and resist apoptosis in injured patients at risk for multiple organ failure. Surgery 126 2 (1999) 198-202
10. Gourlay T. Biomaterial development for cardiopulmonary bypass. Perfusion 16 5 (2001) 381-390
11. Asberg A.E., and Videm V. Activation of neutrophil granulocytes in an in vitro model of a cardiopulmonary bypass. Artif Organs 29 12 (2005) 927-936
12. Asimakopoulos G., and Taylor K.M. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg 66 6 (1998) 2135-2144
13. Smalley D.M., and Ley K. L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 9 2 (2005) 255-266
14. Mandell K.J., and Parkos C.A. The JAM family of proteins. Adv Drug Deliv Rev 57 6 (2005) 857-867
15. Davenpeck K.L., Brummet M.E., Hudson S.A., Mayer R.J., and Bochner B.S. Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. J Immunol 165 5 (2000) 2764-2772
16. Evangelista V., Manarini S., Sideri R., Rotondo S., Martelli N., Piccoli A., Totani L., Piccardoni P., Vestweber D., de Gaetano G., and Cerletti C. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 93 3 (1999) 876-885
17. Boyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl 97 (1968) 9-29
18. Ley K., Lundgren E., Berger E., and Arfors K.E. Shear-dependent inhibition of granulocyte adhesion to cultured endothelium by dextran sulfate. Blood 73 5 (1989) 1324-1330
19. Videm V. Heparin in clinical doses 'primes' granulocytes to subsequent activation as measured by myeloperoxidase release. Scand J Immunol 43 4 (1996) 385-390
20. Suzuki K., Ota H., Sasagawa S., Sakatani T., and Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 132 2 (1983) 345-352
21. Conover W. Practical nonparametric statistics. 3rd ed. (1999), Wiley, New York
22. Partrick D.A., Moore E.E., Moore F.A., Biffl W.L., and Barnett Jr. C.C. Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. Am J Surg 178 6 (1999) 564-569